CCT-62

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCCT-62
Drug Alias NameCCT-62
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCoagulation factor inhibitorsPhosphodiesterase 3 inhibitors
TargetsPhosphodiesterase 3Coagulation factor
Therapy Area/IndicationsBlood Coagulation Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesNational Taiwan University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Taiwan University
Active IndicationsN/A
Inactive IndicationsBlood Coagulation Disorders

Other Information

ATC CodeN/A
Related LinksN/A